soul trial oral semaglutide cardiovascular outcomes 2024 nejm results π§Ώ is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM soul trial oral semaglutide cardiovascular
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 26 - Oct 1












![Your brain is lying to you. [4 months difference] : r/Semaglutide](https://i.redd.it/your-brain-is-lying-to-you-4-months-difference-v0-4ojjl3f3alfh1.jpg?width=2047&format=pjpg&auto=webp&s=3d63eb6d5ea1c59fd3a8e13280f4848d906f4ab2)











